Hereditary angio-oedema is a genetically-determined disease. Usually the disease is due to a deficiency of CĪ inhibitor or less commonly to the production of a functionally inactive molecule. The pathogenesis and clinical features of the disease are reviewed, and discussed in relation to the homeostatic role of CĪ inhibitor. Finally the therapeutic approach to the disease is described and the scientific bases for the newer therapeutic regimes discussed.
Get full access to this article
View all access options for this article.
References
1.
OslerW. Hereditary angioneurotic oedema. Am J Med Sci1888; 95: 362–367
2.
CrowderJRCrowderTR. Five generations of angioneurotic edema. Arch Intern Med1917; 20: 840–852
3.
CockayneEA. Inherited abnormalities of the skin and its appendages. London and Oxford: Oxford University Press1933: 364–370
4.
LandermanNS. Hereditary angioneurotic edema. I. Case reports with a review of the literature. J Allergy Clin Immunol1962; 33: 316–329
5.
GatesRRHuman Genetics Vol. 2. New York: McMillan Press1946; 756–759
6.
DonaldsonVHRosenFS. Hereditary angioneurotic edema: a clinical survey. Pediatrics1966; 37: 1017–1027
7.
DonaldsonVHEvansRR. A biochemical abnormality in hereditary edema: absence of serum C1 esterase. Am J. Med 351963; 37–44
8.
ThorvaldssonSESedlackREGleichGJRuddyS. Angioneurotic edema and deficiency of C1 esterase inhibitor in a 61 year old woman. Ann Intern Med1969; 71: 353–357
9.
RosenFSAlperCAPenskyJKlempererMRDonaldsonVH. Genetically determined heterogeneity of C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest1971; 50: 2143–2149
10.
JacksonCESweetLCHayashiHPaulTD. Evidence for non linkage of genes for HLA and hereditary angioedema. J Allergy Clin. Immunol1978; 61: 331–333
11.
BlumenthalMNDalmassoAPRoitmanBLack of linkage between hereditary angioedema and the A and B loci of the HLA system. Vox Sang1978; 35: 132–136
12.
HarpelPCCooperNR. Studies on human plasma CI− inactivator-enzymes interactions. I. Mechanisms of interaction with CI− plasmin and trypsin. J Clin Invest1975; 55: 593–604
13.
DonaldsonVHRosenFSBingDH. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc. Am Physicians1977; 90: 174–183
14.
CarpenterCBRuddySShehadehIHMüller-EberhardHJMerrilJPAustenKF. Complement metabolism in man: Hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioneurotic edema. J Clin Invest1969; 48: 1495–1505
15.
ShefferALCraigJMWillms-KretschmerKAustenKFRosenFS. Histopathological and ultrastructural observations on tissues from patients with hereditary angioneurotic edemaJ Allergy Clin Immunol1971; 47: 292–297
16.
WillmsKRosenFS, Donaldson VH Observations on the ultrastructure of lesions induced in human and guinea-pig skin by esterase and polypeptide from hereditary angioneurotic edema (H.A.N.E.) plasma. Clin Immunol Immunopathol1975; 4: 174–188
17.
LappinDWhaleyK. Effect of histamine on monocyte complement synthesis. I. Inhibition of C2 production. Clin exp Immunol (in press)1980;
18.
BeckPWillsDDaviesGTLachmannPJSussmanM. A family study of hereditary angioneurotic oedema. Q J Med1973; 42: 317–339
19.
LevyLRLepowIH. Assay and properties of the serum inhibitor of C1 esterase. Proc Soc Exp Biol Med1959; 101: 608–611
20.
GigliIRuddySAustenKF. The stoichiometric measurement of serum inhibitor of the first componenent of complement by the inhibition of immune hemolysis. J Immunol1968; 100: 1154–1164
HadjiyamakeKLachmannPJ. Hereditary angioedema: a review with particular reference to pathogenesis and treatment. Clin Allergy19711: 221–233
23.
FrankMMSergentJSKaneMAAllingDW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double blind study. N Engl J Med1972; 287: 808–812
24.
Korsan-BengtsenKYsanderLBlohmeGTibblinE. Extensive muscle necrosis after long-term treatment with aminocaproic acid (EACA) in a case of hereditary periodic edema. Acta Med Scand1969; 185: 341–346
25.
ShefferALAustenKFRosenFS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med1972; 287, 452–454
ShefferALFearonDTAustenKF. Methyltestosterone therapy in hereditary angioedema. Ann Intern Med1977; 86: 306–308
28.
GelfandJASherinsRJAllingDWFrankMM. Treatment of hereditary angioneurotic edema with Danazol. N Engl J Med1976; 295: 1444–1448
29.
RosseWFLogueGISilbermanHR. The effect of synthetic androgens on the clinical course of CI− esterase inhibitor (CI−-INH) levels in hereditary angioneurotic edema (H.A.N.E.)Clin Res1976; 24: 482 (abstract)
AgostiniAMarasiniBCicardiMMartinignoniGC. Intermittent therapy with danazol in hereditary angioedema. Lancet1978; 1, 453
33.
PickeringRJKellyJRGoodRAGuwurzH. Replacement therapy in hereditary angioedema— successful treatment of two patients with fresh frozen plasma. Lancet1969; 1: 326–330
34.
RosenFSSustenKF (1969) The ‘neurotic edema’ (hereditary angioedema). N Engl J Med1969; 280: 1356–1357
